Media Coverage
CRISPR Dispute Likely to Continue in Federal Courts
8 December 2016
Life Sciences Intellectual Property Review (subscription required)
Intellectual Property partner Brian Nolan (New York) was quoted in this article discussing the CRISPR/Cas9 patent hearing on December 6 between The Broad Institute and University of California, Berkeley (UCB).